BioSpace News Archive

Genetown

OXiGENE Participates In 4th Annual International Conference On Antiangiogenesis

October 11, 2006
·
1 min read
Biotech Bay

Dynavax Technologies Corporation Announces Closing Of Common Stock Offering And Exercise Of Underwriter’s Over-Allotment Option

October 11, 2006
·
2 min read
Pharm Country

ZIOPHARM Oncology, Inc. To Present At Biotechnology Industry Organization (BIO) Investor Forum

October 11, 2006
·
1 min read
MethylGene To Present At Biotechnology Industry Organization (BIO) Investor Forum 2006

October 11, 2006
·
1 min read
Biotech Bay

Lipid Sciences, Inc. HDL Selective Delipidation Technology Represented At The New York Advances In Cardiac Endovascular Therapies (ACE) Meeting

October 11, 2006
·
1 min read
Miraculins Inc. Announces Successful ELISA Test Development

October 11, 2006
·
1 min read
Drug Development

Osiris Therapeutics, Inc. Receives Approval From Health Canada To Conduct Phase III Clinical Trial For Lead Stem Cell Drug

October 11, 2006
·
1 min read
Biotech Beach

CytRx Corporation To Present At The 2006 Biotechnology Industry Organization (BIO) InvestorForum

October 11, 2006
·
1 min read
Drug Development

Accentia Biopharmaceuticals Majority-Owned Subsidiary Biovest International, Inc. Receives Rare Disease Designation From European Drug Agency For Follicular Non-Hodgkin’s Lymphoma

October 11, 2006
·
1 min read
Drug Development

Alnylam Pharmaceuticals Initiates Phase I Clinical Study Of Inhaled Formulation Of ALN-RSV01, An RNAi Therapeutic For The Treatment Of Respiratory Syncytial Virus (RSV) Infection

October 11, 2006
·
1 min read